+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

In Vitro Diagnostics Market, Industry Trends and Global Forecasts to 2035: Distribution by Test Type, Type of Offering, Type of Technology, Therapeutic Area, End Users and Geographical Regions

  • PDF Icon

    Report

  • 188 Pages
  • September 2024
  • Region: Global
  • Roots Analysis
  • ID: 6006030
Description Jump to:

The In Vitro Diagnostics Market is valued at USD 108 billion in 2024 growing at a CAGR of 5.2% during the forecast period 2024-2035.

In vitro diagnostic tests (IVD) are laboratory tests that examine human samples, such as blood or tissue, outside the human body. The term "in vitro" comes from Latin, meaning "within the glass," which refers to the testing of biological samples in a controlled environment. These tests play a crucial role in diagnosing diseases, monitoring treatment progress, and predicting healthcare outcomes. IVD products are used in both industrial and clinical settings, and despite being non-invasive, they are subject to the same regulatory requirements as medical devices.

The in vitro diagnostic industry offers a wide range of products, from simple self-test glucose monitoring devices to complex laboratory procedures. These tests can identify blood types, diagnose cancer, and profile kidney function, among other applications. According to the World Health Organization, there are over 40,000 IVD products available in the market, highlighting the importance of diagnostics in healthcare.

In fact, over 70% of healthcare decisions are based on laboratory test results, underscoring the critical role of IVD products in patient care. Given the benefits of rapid diagnostic results and improved patient outcomes, the global in vitro diagnostics market is expected to grow at a healthy rate over the forecast period. The growth of the IVD market can be attributed to factors such as increasing demand for point-of-care diagnostics devices, rapid testing, and the growing prevalence of chronic diseases.

Key Market Segments

Test Type

  • Laboratory Testing
  • Point-of-Care Testing

Type of Offering

  • Reagents
  • Instruments
  • Services

Type of Technology

  • Clinical Chemistry
  • Hematology 
  • Immunoassay
  • Molecular Diagnostics
  • Others

Therapeutic Area

  • Autoimmune Diseases
  • Cardiovascular Disorders
  • Diabetes
  • Infectious Diseases
  • Renal Disorders
  • Oncological Disorders
  • Others

End Users

  • Hospitals
  • Laboratories
  • Others

Key Geographical Regions

  • North America (US, Canada)
  • Europe (Austria, Belgium, France, Germany, Italy, Netherlands, Spain,
    Switzerland, UK, Rest of the Europe)
  • Asia (China, India, Indonesia, Japan, Singapore, South Korea, Thailand,
    Rest of Asia)
  • Latin America (Argentina, Brazil, Mexico, Rest of Latin America)
  • Middle East and North Africa (Egypt, Israel, Saudi Arabia, Rest of Middle
    East and North Africa)
  • Rest of the World

Research Coverage:

  • This chapter provides an overview of key concepts in the field of in vitro diagnostics, including the classification of in vitro diagnostic products, the therapeutic areas they target, and the various types of in vitro diagnostic tests. It also highlights the challenges faced in the in vitro diagnostics domain and presents recent advancements in this market space.
  • This chapter provides an overview of the leading players in the in vitro diagnostics (IVD) market. The analysis includes information on their year of establishment, company size, location of headquarters and annual revenues of the players (FY23, USD billion). Further, it highlights a detailed assessment of the in vitro diagnostic solutions based on several relevant parameters, such as type of technology used (clinical chemistry, hematology, immunoassay, molecular diagnostics, urinalysis), diagnostic applications (autoimmune, cardiology, diabetes, gynecology, healthcare-associated infections, infectious diseases, oncological disorders, renal, sexually transmitted infections / diseases).
  • This analysis evaluates the top players in the in vitro diagnostics market, considering factors such as years of experience, company competitiveness, and technological capabilities. It provides insights into their strengths and weaknesses.
  • Comprehensive company profiles of leading IVD market players are provided, featuring detailed information on each company's background, financial performance, product offerings, and recent developments. This includes a brief overview, financial information, in vitro diagnostic products and services, recent developments, and expert analysis and future outlook for each company.
  • Profiles of prominent IVD players are presented, highlighting key company details, financial performance, and product offerings. Each profile includes a brief overview, including year of establishment, number of employees, headquarters location, and executive team members. Additionally, financial information, in vitro diagnostic products and services, recent developments, and expert analysis of future outlook are provided for each company.
  • A comprehensive Porter's Five Forces analysis is conducted, examining the competitive forces driving the global IVD market. The report assesses the threat of new entrants, bargaining power of buyers and suppliers, threats of substitute products, and rivalry among existing competitors to provide a detailed understanding of the market's dynamics.
  • The report analyzes the factors influencing the growth of the IVD market, including key drivers, restraints, emerging opportunities, and existing challenges. It identifies and examines the impact of these factors on the market's dynamics, providing a comprehensive understanding of the industry's growth prospects.
  • The report provides a comprehensive estimate of the current IVD market size, opportunity, and future growth potential from 2024 to 2035. Our analysis is based on multiple parameters, adoption trends, and primary validations. We have provided an informed estimate of market evolution, including the likely distribution of current and forecasted opportunity. To account for future uncertainties, we have also presented three forecast scenarios: conservative, base, and optimistic, representing different tracks of the industry's growth. This detailed analysis helps stakeholders understand the market's trajectory and make informed decisions.
  • Comprehensive projection of the current and future in IVD market across different test types, such as laboratory testing and point-of-care testing.
  • Detailed predictions of the current and future in vitro diagnostics market across different types of technologies, such as clinical chemistry, hematology, immunoassay, molecular diagnostics, and others.
  • Comprehensive projections of the current and future in vitro diagnostic industry across different therapeutic areas, such as autoimmune diseases, cardiological disorders, diabetes, infectious diseases, renal disorders, oncological disorders, and others.
  • Detailed predictions of the current and future in vitro diagnostics market across different end users, such as hospitals, laboratories and others.
  • Detailed projection of the current and future in vitro diagnostic industry across key geographical regions, such as North America, Europe, Asia, Latin America, Middle East and North Africa and Rest of the World. 

Key Benefits of Buying this Report

  • The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
  • Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
  • The report provides stakeholders with a pulse on the In Vitro Diagnostics Market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Leading Market Companies

  • Abbott Laboratories
  • Agilent
  • Becton Dickinson
  • bioMérieux
  • Bio-Rad
  • Danaher Corporation
  • DiaSorin
  • Exact Sciences
  • Fujifilm
  • Gold Standard Diagnostics
  • Grifols
  • Hologic
  • Illumina
  • LabCorp
  • Qiagen
  • Quest Diagnostics
  • QuidelOrtho
  • Roche
  • Siemens Healthineers
  • Sysmex
  • Thermo Fisher Scientific
  • Werfen

Table of Contents

1. PREFACE
1.1. Market Overview
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Project Methodology
2.4. Forecast Methodology
2.5. Robust Quality Control
2.6. Key Market Segmentations
2.7. Key Considerations
2.7.1. Demographics
2.7.2. Economic Factors
2.7.3. Government Regulations
2.7.4. Supply Chain
2.7.5. COVID Impact
2.7.6. Market Access
2.7.7. Healthcare Policies
2.7.8. Industry Consolidation

3. ECONOMIC AND OTHER PROJECT SPECIFIC CONSIDERATIONS
3.1. Chapter Overview
3.2. Market Dynamics
3.2.1. Time Period
3.2.1.1. Historical Trends
3.2.1.2. Current and Forecasted Estimates
3.2.2. Currency Coverage and Foreign Exchange Rate
3.2.2.1. Major Currencies Affecting the Market
3.2.2.2. Factors Affecting Currency Fluctuations and Foreign Exchange Rates
3.2.2.3. Impact of Foreign Exchange Rate Volatility on the Market
3.2.2.4. Strategies for Mitigating Foreign Exchange Risk
3.2.3. Trade Policies
3.2.3.1. Impact of Trade Barriers on the Market
3.2.3.2. Strategies for Mitigating the Risks Associated with Trade Barriers

3.2.4. Recession
3.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
3.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
3.2.5. Inflation
3.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
3.2.5.2. Potential Impact of Inflation on the Market Evolution

4. INTRODUCTION
4.1. Chapter Overview
4.2. Overview of In Vitro Diagnostics
4.3. Classification of In Vitro Diagnostic Products
4.4. Types of In Vitro Diagnostic Tests
4.5. Therapeutic Areas Targeted by In Vitro Diagnostic Solutions
4.6. Challenges in the In Vitro Diagnostics Domain
4.7. Recent Developments in the In Vitro Diagnostics Domain

5. MARKET OVERVIEW: LEADING IN VITRO DIAGNOSTICS SOLUTIONS
5.1. Chapter Overview
5.2. In Vitro Diagnostics: Overall Market Landscape
5.2.1. Analysis by Type of Technology
5.2.2. Analysis by Diagnostic Applications
5.3. In Vitro Diagnostics: Solution Providers Landscape
5.3.1. Analysis by Year of Establishment
5.3.2. Analysis by Company Size
5.3.3. Analysis by Location of Headquarters
5.3.4. Analysis by Annual Revenues (FY23, USD Billion)

6. IN VITRO DIAGNOSTIC SOLUTION PROVIDERS: COMPANY COMPETITIVENESS ANALYSIS
6.1. Methodology and Key Parameters Assessed
6.2. In Vitro Diagnostic Solution Providers: Competitiveness Analysis
6.3. Benchmarking Analysis: Leading In Vitro Diagnostic Solutions Providers
6.3.1. Benchmarking of Companies
6.3.1.1. Abott: Benchmarking Analysis
6.3.1.2. Agilent: Benchmarking Analysis
6.3.1.3. BD: Benchmarking Analysis
6.3.1.4. bioMérieux: Benchmarking Analysis
6.3.1.5. Bio-Rad: Benchmarking Analysis
6.3.1.6. Danaher: Benchmarking Analysis
6.3.1.7. Qiagen: Benchmarking Analysis
6.3.1.8. QuidelOrtho: Benchmarking Analysis
6.3.1.9. Roche: Benchmarking Analysis
6.3.1.10. Siemens Healthineers: Benchmarking Analysis
6.3.2. Benchmarking of Parameters
6.3.2.1. Leading In Vitro Diagnostics Solution Providers: Benchmarking by Competitiveness
6.3.2.2. Leading In Vitro Diagnostic Solution Providers: Benchmarking by Type of Technology Score
6.3.2.3. Leading In Vitro Diagnostic Solution Providers: Benchmarking by Diagnostic Applications Score

7. DETAILED COMPANY PROFILES
7.1. Chapter Overview
7.2. Abbott
7.2.1. Company Overview
7.2.2. Financial Information
7.2.3. In Vitro Diagnostic Offerings
7.2.4. Recent Developments and Future Outlook
7.3. Agilent
7.3.1. Company Overview
7.3.2. Financial Information
7.3.3. In Vitro Diagnostic Offerings
7.3.4. Recent Developments and Future Outlook
7.4. BD
7.4.1. Company Overview
7.4.2. Financial Information
7.4.3. In Vitro Diagnostic Offerings
7.4.4. Recent Developments and Future Outlook
7.5. bioMérieux
7.5.1. Company Overview
7.5.2. Financial Information
7.5.3. In Vitro Diagnostic Offerings
7.5.4. Recent Developments and Future Outlook
7.6. Bio-Rad
7.6.1. Company Overview
7.6.2. Financial Information
7.6.3. In Vitro Diagnostic Offerings
7.6.4. Recent Developments and Future Outlook
7.7. Danaher
7.7.1. Company Overview
7.7.2. Financial Information
7.7.3. In Vitro Diagnostic Offerings
7.7.4. Recent Developments and Future Outlook
7.8. Qiagen
7.8.1. Company Overview
7.8.2. Financial Information
7.8.3. In Vitro Diagnostic Offerings
7.8.4. Recent Developments and Future Outlook
7.9. Quest Diagnostics
7.9.1. Company Overview
7.9.2. Financial Information
7.9.3. In Vitro Diagnostic Offerings
7.9.4. Recent Developments and Future Outlook
7.10. QuidelOrtho
7.10.1. Company Overview
7.10.2. Financial Information
7.10.3. In Vitro Diagnostic Offerings
7.10.4. Recent Developments and Future Outlook
7.11. Roche
7.11.1. Company Overview
7.11.2. Financial Information
7.11.3. In Vitro Diagnostic Offerings
7.11.4. Recent Developments and Future Outlook
7.12. Siemens Healthineers
7.12.1. Company Overview
7.12.2. Financial Information
7.12.3. In Vitro Diagnostic Offerings
7.12.4. Recent Developments and Future Outlook
7.13. Sysmex
7.13.1. Company Overview
7.13.2. Financial Information
7.13.3. In Vitro Diagnostic Offerings
7.13.4. Recent Developments and Future Outlook

8. SHORT COMPANY PROFILES
8.1. Chapter Overview
8.2. DiaSorin
8.2.1. Company Overview
8.2.2. Financial Information
8.2.3. Recent Developments
8.2.4. In Vitro Diagnostic Offerings
8.3. Exact Sciences
8.3.1. Company Overview
8.3.2. Financial Information
8.3.3. Recent Developments
8.3.4. In Vitro Diagnostic Offerings
8.4. Fujifilm
8.4.1. Company Overview
8.4.2. Financial Information
8.4.3. Recent Developments
8.4.4. In Vitro Diagnostic Offerings
8.5. Gold Standard Diagnostics
8.5.1. Company Overview
8.5.2. Financial Information
8.5.3. Recent Developments
8.5.4. In Vitro Diagnostic Offerings
8.6. Grifols
8.6.1. Company Overview
8.6.2. Financial Information
8.6.3. Recent Developments
8.6.4. In Vitro Diagnostic Offerings
8.7. Hologic
8.7.1. Company Overview
8.7.2. Financial Information
8.7.3. Recent Developments
8.7.4. In Vitro Diagnostic Offerings
8.8. Illumina
8.8.1. Company Overview
8.8.2. Financial Information
8.8.3. Recent Developments
8.8.4. In Vitro Diagnostic Offerings
8.9. LabCorp
8.9.1. Company Overview
8.9.2. Financial Information
8.9.3. Recent Developments
8.9.4. In Vitro Diagnostic Offerings
8.10. Thermo Fisher Scientific
8.10.1. Company Overview
8.10.2. Financial Information
8.10.3. Recent Developments
8.10.4. In Vitro Diagnostic Offerings
8.11. Werfen
8.11.1. Company Overview
8.11.2. Financial Information
8.11.3. Recent Developments
8.11.4. In Vitro Diagnostic Offerings

9. PORTER’S FIVE FORCES ANALYSIS
9.1. Chapter Overview
9.2. Methodology and Assumptions
9.3. Key Parameters
9.3.1. Threats of New Entrants
9.3.2. Bargaining Power of Buyers
9.3.3. Bargaining Power of Suppliers
9.3.4. Threats of Substitute Products
9.3.5. Rivalry among Existing Competitors
9.4. Porter’s Five Force Analysis: Harvey Ball Analysis
9.5. Concluding Remarks

10. MARKET IMPACT ANALYSIS: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES
10.1. Chapter Overview
10.2. Market Drivers
10.3. Market Restraints
10.4. Market Opportunities
10.5. Market Challenges
10.6. Conclusion

11. GLOBAL IN VITRO DIAGNOSTICS MARKET
11.1. Chapter Overview
11.2. Assumptions and Methodology
11.3. Global In Vitro Diagnostics Market, Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
11.3.1. Scenario Analysis
11.3.1.1. Conservative Scenario
11.3.1.2. Optimistic Scenario
11.3.2. Key Market Segmentations

12. IN VITRO DIAGNOSTICS MARKET, BY TEST TYPE
12.1. Chapter Overview
12.2. Assumptions and Methodology
12.3. In Vitro Diagnostics Market: Distribution by Test Type, 2018, 2024 and 2035
12.3.1. Laboratory Testing: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
12.3.2. Point-of-Care Testing: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
12.4. Data Triangulation and Validation

13. IN VITRO DIAGNOSTICS MARKET, BY TYPE OF OFFERING
13.1. Chapter Overview
13.2. Assumptions and Methodology
13.3. In Vitro Diagnostics Market: Distribution by Type of Offering, 2018, 2024 and 2035
13.3.1. Reagents: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
13.3.2. Instruments: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
13.3.2.1. In-house Instruments: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
13.3.2.2. Outsourced Instruments: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
13.3.3. Services: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
13.4. Data Triangulation and Validation

14. IN VITRO DIAGNOSTICS MARKET, BY TYPE OF TECHNOLOGY
14.1. Chapter Overview
14.2. Assumptions and Methodology
14.3. In Vitro Diagnostics Market: Distribution by Type of Technology, 2018, 2024 And 2035
14.3.1. Immunoassay: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
14.3.1.1. Chemiluminescence Immunoassays: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
14.3.1.2. ELISA: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
14.3.1.3. ELISPOT: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
14.3.1.4. Immunofluorescence Assays: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
14.3.1.5. Rapid Tests: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
14.3.1.6. Other Immunoassays: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
14.3.2. Clinical Chemistry: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
14.3.2.1. Electrolyte Panels: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
14.3.2.2. Lipid Profiles: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
14.3.2.3. Liver Panels: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
14.3.2.4. Metabolic Panels: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
14.3.2.5. Renal Profiles: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
14.3.2.6. Other Clinical Chemistry Tests: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
14.3.3. Molecular Diagnostics: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
14.3.3.1. PCR: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
14.3.3.2. In situ Hybridization: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
14.3.3.3. Isothermal Nucleic Acid Amplification Technology: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
14.3.3.4. Next Generation Sequencing: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
14.3.3.5. Microarrays: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
14.3.3.6. Mass Spectrometry: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
14.3.3.7. Other Molecular Diagnostic Tests: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
14.3.4. Hematology: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
14.3.5. Other Technologies: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
14.4. Data Triangulation and Validation

15. IN VITRO DIAGNOSTICS MARKET, BY THERAPEUTIC AREA
15.1. Chapter Overview
15.2. Assumptions and Methodology
15.3. In Vitro Diagnostics Market: Distribution by Therapeutic Area, 2018, 2024 and 2035
15.3.1. Infectious Diseases: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
15.3.1.1. COVID-19: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
15.3.1.2. Healthcare-associated Infections: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
15.3.1.3. Hepatitis: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
15.3.1.4. HIV: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
15.3.1.5. Respiratory Infections (Excluding COVID-19): Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
15.3.1.6. STD: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
15.3.1.7. Other Infectious Diseases: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
15.3.2. Cardiovascular Diseases: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
15.3.3. Oncological Disorders: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
15.3.4. Diabetes: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
15.3.5. Autoimmune Diseases: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
15.3.6. Renal Disorders: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
15.3.7. Other Therapeutic Areas: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
15.4. Data Triangulation and Validation

16. IN VITRO DIAGNOSTICS MARKET, BY END USERS
16.1. Chapter Overview
16.2. Assumptions and Methodology
16.3. In Vitro Diagnostics Market: Distribution by End Users, 2018, 2024 and 2035
16.3.1. Hospitals: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
16.3.2. Laboratories: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
16.3.2.1. Large Laboratories: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
16.3.2.2. Small and Medium-sized Laboratories: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
16.3.3. Other End Users: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
16.4. Data Triangulation and Validation

17. IN VITRO DIAGNOSTICS MARKET, BY GEOGRAPHY
17.1. Chapter Overview
17.2. Assumptions and Methodology
17.3. In Vitro Diagnostics Market: Distribution by Key Geographies, 2018, 2024 And 2035
17.3.1. North America: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.1.1. US: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.1.2. Canada: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.2. Europe: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.2.1. Austria: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.2.2. Belgium: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.2.3. France: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.2.4. Germany: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.2.5. Italy: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.2.6. Netherlands: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.2.7. Poland: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.2.8. Spain: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.2.9. Switzerland: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.2.10. UK: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.2.11. Rest of the Europe: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.3. Asia: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.3.1. China: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.3.2. India: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.3.3. Indonesia: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.3.4. Japan: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.3.5. Singapore: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.3.6. South Korea: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.3.7. Thailand: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.3.8. Rest of the Asia: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.4. Latin America: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.4.1. Brazil: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.4.2. Argentina: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.4.3. Mexico: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.4.4. Rest of Latin America: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.5. Middle East and North Africa: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.5.1. Egypt: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.5.2. Israel: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.5.3. Saudi Arabia: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.5.4. Rest of Middle East and North Africa: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.6. Rest of the World: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.6.1. Australia: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.3.6.2. New Zealand: Historical Trends (2018-2023) and Forecasted Estimates (2024-2035)
17.4. Data Triangulation and Validation

18. IN VITRO DIAGNOSTICS MARKET, BY LEADING PLAYERS
18.1. Chapter Overview
18.2. Assumptions and Methodology
18.3. In Vitro Diagnostics Market: Distribution of Leading Players by Annual Revenue (FY23, USD Billion)

19. EXECUTIVE INSIGHTS
19.1. Chapter Overview
19.2. Teco Diagnostics
19.2.1. Company Snapshot
19.2.2. Interview Transcript: Kiranjit Kaur Dhaliwal, Research and Development Associate (Q2 2024)
19.3. BD Biosciences
19.3.1. Company Snapshot
19.3.2. Interview Transcript: Milan Aggarwal, Senior Scientist (Q2 2024)

20. APPENDIX I: TABULATED DATA21. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
LIST OF FIGURES
Figure 4.1 Classification of In Vitro Diagnostic Products
Figure 4.2 Therapeutic Areas Targeted by In Vitro Diagnostic Solutions
Figure 4.3 Challenges in the In Vitro Diagnostics Domain
Figure 5.1 In Vitro Diagnostic Solutions: Distribution by Type of Technology
Figure 5.2 In Vitro Diagnostic Solutions: Distribution by Diagnostic Applications
Figure 5.3 In Vitro Diagnostics Solution Providers: Distribution by Year of Establishment
Figure 5.4 In Vitro Diagnostics Solution Providers: Distribution by Company Size
Figure 5.5 In Vitro Diagnostics Solution Providers: Distribution by Location of Headquarters
Figure 5.6 In Vitro Diagnostics Solution Providers: Distribution by Annual Revenues (FY23, USD Billion)
Figure 6.1 In Vitro Diagnostic Solutions: 3-D Bubble Chart
Figure 6.2 Abbott: Benchmarking Analysis
Figure 6.3 Agilent: Benchmarking Analysis
Figure 6.4 BD: Benchmarking Analysis
Figure 6.5 bioMérieux: Benchmarking Analysis
Figure 6.6 Bio-Rad: Benchmarking Analysis
Figure 6.7 Danaher: Benchmarking Analysis
Figure 6.8 Qiagen: Benchmarking Analysis
Figure 6.9 QuidelOrtho: Benchmarking Analysis
Figure 6.10 Roche: Benchmarking Analysis
Figure 6.11 Siemens Healthineers: Benchmarking Analysis
Figure 6.12 Leading In Vitro Diagnostic Solution Providers: Benchmarking by Competitiveness
Figure 6.13 Leading In Vitro Diagnostic Solution Providers: Benchmarking by Technology Score
Figure 6.14 Leading In Vitro Diagnostic Solution Providers: Benchmarking by Applications Score
Figure 7.1 Abbott: Financial Information (USD Billion)
Figure 7.2 Agilent: Financial Information (USD Billion)
Figure 7.3 BD: Financial Information (USD Billion)
Figure 7.4 bioMérieux: Financial Information (EUR Billion)
Figure 7.5 Bio-Rad: Financial Information (USD Billion)
Figure 7.6 Danaher: Financial Information (USD Billion)
Figure 7.7 Qiagen: Financial Information (USD Billion)
Figure 7.8 Quest Diagnostics: Financial Information (USD Billion)
Figure 7.9 QuidelOrtho: Financial Information (USD Billion)
Figure 7.10 Roche: Financial Information (CHF Billion)
Figure 7.11 Siemens Healthineers: Financial Information (EUR Billion)
Figure 7.12 Sysemx: Financial Information (YEN Billion)
Figure 8.1 DiaSorin: Financial Information (USD Billion)
Figure 8.2 Exact Sciences: Financial Information (USD Billion)
Figure 8.3 Fujifilm: Financial Information (USD Billion)
Figure 8.4 Gold Standard Diagnostics: Financial Information (EUR Billion)
Figure 8.5 Grifols: Financial Information (USD Billion)
Figure 8.6 Hologic: Financial Information (USD Billion)
Figure 8.7 Illumina: Financial Information (USD Billion)
Figure 8.8 LabCorp: Financial Information (USD Billion)
Figure 8.9 Thermo Fisher Scientific: Financial Information (USD Billion)
Figure 8.10 Werfen: Financial Information (CHF Billion)
Figure 9.1 Threats of New Entrants
Figure 9.2 Bargaining Power of Buyers
Figure 9.3 Bargaining Power of Suppliers
Figure 9.4 Threats of Substitute Products
Figure 9.5 Rivalry among Existing Competitors
Figure 9.6 Porter’s Five Force Analysis: Harvey Ball Analysis
Figure 10.1 Market Drivers
Figure 10.2 Market Restraints
Figure 10.3 Market Opportunities
Figure 10.4 Market Challenges
Figure 11.1 Global In Vitro Diagnostics Market, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 11.2 Global In Vitro Diagnostics Market, Forecasted Estimates (till 2035): Conservative Scenario (USD Billion)
Figure 11.3 Global In Vitro Diagnostics Market, Forecasted Estimates (till 2035): Optimistic Scenario (USD Billion)
Figure 12.1 In Vitro Diagnostics Market: Distribution by Test Type, 2018, 2024 And 2035
Figure 12.2 In Vitro Diagnostics Market for Laboratory Testing, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 12.3 In Vitro Diagnostics Market for Point-of-Care Testing, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 13.1 In Vitro Diagnostics Market: Distribution by Type of Offering, 2018, 2024 And 2035
Figure 13.2 In Vitro Diagnostics Market for Reagents, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 13.3 In Vitro Diagnostics Market for Instruments, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 13.4 In Vitro Diagnostics Market for In-house Instruments, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 13.5 In Vitro Diagnostics Market for Outsourced Instruments, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 13.6 In Vitro Diagnostics Market for Services, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 14.1 In Vitro Diagnostics Market: Distribution by Type of Technology, 2018, 2024 And 2035
Figure 14.2 In Vitro Diagnostics Market for Immunoassay, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 14.3 In Vitro Diagnostics Market for Chemiluminescence Immunoassays, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 14.4 In Vitro Diagnostics Market for ELISA, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 14.5 In Vitro Diagnostics Market for ELISPOT, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 14.6 In Vitro Diagnostics Market for Immunofluorescence Assays, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 14.7 In Vitro Diagnostics Market for Rapid Tests, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 14.8 In Vitro Diagnostics Market for Other Immunoassays, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 14.9 In Vitro Diagnostics Market for Clinical Chemistry, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 14.10 In Vitro Diagnostics Market for Electrolyte Panels, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 14.11 In Vitro Diagnostics Market for Lipid Profiles, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 14.12 In Vitro Diagnostics Market for Liver Panels, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 14.13 In Vitro Diagnostics Market for Metabolic Panels, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 14.14 In Vitro Diagnostics Market for Renal Profiles, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 14.15 In Vitro Diagnostics Market for Other Clinical Chemistry Tests, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 14.16 In Vitro Diagnostics Market for Molecular Diagnostics, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 14.17 In Vitro Diagnostics Market for PCR, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 14.18 In Vitro Diagnostics Market for In situ Hybridization, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 14.19 In Vitro Diagnostics Market for Isothermal Nucleic Acid Amplification Technology, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 14.20 In Vitro Diagnostics Market for Next Generation Sequencing, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 14.21 In Vitro Diagnostics Market for Microarrays, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 14.22 In Vitro Diagnostics Market for Mass Spectrometry, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 14.23 In Vitro Diagnostics Market for Other Molecular Diagnostic Tests, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 14.24 In Vitro Diagnostics Market for Hematology, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 14.25 In Vitro Diagnostics Market for Other Technologies, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 15.1 In Vitro Diagnostics Market: Distribution by Therapeutic Area, 2018, 2024 And 2035
Figure 15.2 In Vitro Diagnostics Market for Infectious Diseases, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 15.3 In Vitro Diagnostics Market for COVID-19, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 15.4 In Vitro Diagnostics Market for Healthcare-associated Infections, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 15.5 In Vitro Diagnostics Market for Hepatitis, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 15.6 In Vitro Diagnostics Market for HIV, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 15.7 In Vitro Diagnostics Market for Respiratory Infections (Excluding COVID-19), Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 15.8 In Vitro Diagnostics Market for STD, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 15.9 In Vitro Diagnostics Market for Other Infectious Diseases, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 15.10 In Vitro Diagnostics Market for Cardiovascular Diseases, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 15.11 In Vitro Diagnostics Market for Oncological Disorders, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 15.12 In Vitro Diagnostics Market for Diabetes, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 15.13 In Vitro Diagnostics Market for Autoimmune Diseases, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 15.14 In Vitro Diagnostics Market for Renal Disorders, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 15.15 In Vitro Diagnostics Market for Other Therapeutic Areas, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 16.1 In Vitro Diagnostics Market: Distribution by End Users, 2018, 2024 And 2035
Figure 16.2 In Vitro Diagnostics Market for Hospitals, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 16.3 In Vitro Diagnostics Market for Laboratories, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 16.4 In Vitro Diagnostics Market for Large Laboratories, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 16.5 In Vitro Diagnostics Market for Small and Medium-sized Laboratories, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 16.6 In Vitro Diagnostics Market for Other End Users, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.1 In Vitro Diagnostics Market: Distribution by Geographies, 2018, 2024 And 2035
Figure 17.2 In Vitro Diagnostics Market in North America, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.3 In Vitro Diagnostics Market in the US, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.4 In Vitro Diagnostics Market in Canada, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.5 In Vitro Diagnostics Market in Europe, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.6 In Vitro Diagnostics Market in Austria, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.7 In Vitro Diagnostics Market in Belgium, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.8 In Vitro Diagnostics Market in France, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.9 In Vitro Diagnostics Market in Germany, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.10 In Vitro Diagnostics Market in Italy, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.11 In Vitro Diagnostics Market in the Netherlands, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.12 In Vitro Diagnostics Market in Poland, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.13 In Vitro Diagnostics Market in Spain, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.14 In Vitro Diagnostics Market in Switzerland, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.15 In Vitro Diagnostics Market in the UK, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.16 In Vitro Diagnostics Market in Rest of the Europe, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.17 In Vitro Diagnostics Market in Asia, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.18 In Vitro Diagnostics Market in China, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.19 In Vitro Diagnostics Market in India, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.20 In Vitro Diagnostics Market in Indonesia, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.21 In Vitro Diagnostics Market in Japan, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.22 In Vitro Diagnostics Market in Singapore, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.23 In Vitro Diagnostics Market in South Korea, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.24 In Vitro Diagnostics Market in Thailand, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.25 In Vitro Diagnostics Market in Rest of the Asia, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.26 In Vitro Diagnostics Market in Latin America, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.27 In Vitro Diagnostics Market in Brazil, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.28 In Vitro Diagnostics Market in Argentina, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.29 In Vitro Diagnostics Market in Mexico, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.30 In Vitro Diagnostics Market in Rest of Latin America, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.31 In Vitro Diagnostics Market in Middle East and North Africa, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.32 In Vitro Diagnostics Market in Egypt, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.33 In Vitro Diagnostics Market in Israel, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.34 In Vitro Diagnostics Market in Saudi Arabia, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.35 In Vitro Diagnostics Market in Rest of Middle East and North Africa, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.36 In Vitro Diagnostics Market in Rest of the World, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.37 In Vitro Diagnostics Market in Australia, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 17.38 In Vitro Diagnostics Market in New Zealand, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Figure 18.1 In Vitro Diagnostics Market: Distribution of Leading Players by Annual Revenue (FY23, USD Billion)

LIST OF TABLES
Table 5.1 Leading Players Engaged in In Vitro Diagnostics Market: Information on Year of Establishment, Headquarters, Company Revenues, Type of Technology and Diagnostic Applications
Table 7.1 Abbott: Company Overview
Table 7.2 Abbott: Recent Developments and Future Outlook
Table 7.3 Agilent: Company Overview
Table 7.4 Agilent: Recent Developments and Future Outlook
Table 7.5 BD: Company Overview
Table 7.6 BD: Recent Developments and Future Outlook
Table 7.7 bioMérieux: Company Overview
Table 7.8 bioMérieux: Recent Developments and Future Outlook
Table 7.9 Bio-Rad: Company Overview
Table 7.10 Bio-Rad: Recent Developments and Future Outlook
Table 7.11 Danaher: Company Overview
Table 7.12 Danaher: Recent Developments and Future Outlook
Table 7.13 Qiagen: Company Overview
Table 7.14 Qiagen: Recent Developments and Future Outlook
Table 7.15 Quest Diagnostics: Company Overview
Table 7.16 Quest Diagnostics: Recent Developments and Future Outlook
Table 7.17 QuidelOrtho: Company Overview
Table 7.18 QuidelOrtho: Recent Developments and Future Outlook
Table 7.19 Roche: Company Overview
Table 7.20 Roche: Recent Developments and Future Outlook
Table 7.21 Siemens Healthineers: Company Overview
Table 7.22 Siemens Healthineers: Recent Developments and Future Outlook
Table 7.23 Sysmex: Company Overview
Table 7.24 Sysmex: Recent Developments and Future Outlook
Table 8.1 DiaSorin: Company Overview
Table 8.2 DiaSorin: Recent Developments and Future Outlook
Table 8.3 Exact Sciences: Company Overview
Table 8.4 Exact Sciences: Recent Developments and Future Outlook
Table 8.5 Fujifilm: Company Overview
Table 8.6 Fujifilm: Recent Developments and Future Outlook
Table 8.7 Gold Standard Diagnostics: Company Overview
Table 8.8 Gold Standard Diagnostics: Recent Developments and Future Outlook
Table 8.9 Grifols: Company Overview
Table 8.10 Grifols: Recent Developments and Future Outlook
Table 8.11 Hologic: Company Overview
Table 8.12 Hologic: Recent Developments and Future Outlook
Table 8.13 Illumina: Company Overview
Table 8.14 Illumina: Recent Developments and Future Outlook
Table 8.15 LabCorp: Company Overview
Table 8.16 LabCorp: Recent Developments and Future Outlook
Table 8.17 Thermo Fisher Scientific: Company Overview
Table 8.18 Thermo Fisher Scientific: Recent Developments and Future Outlook
Table 8.19 Werfen: Company Overview
Table 8.20 Werfen: Recent Developments and Future Outlook
Table 23.1 In Vitro Diagnostic Solutions: Distribution by Type of Technology
Table 23.2 In Vitro Diagnostic Solutions: Distribution by Diagnostic Applications
Table 23.3 In Vitro Diagnostics Solution Providers: Distribution by Year of Establishment
Table 23.4 In Vitro Diagnostics Solution Providers: Distribution by Company Size
Table 23.5 In Vitro Diagnostics Solution Providers: Distribution by Location of Headquarters
Table 23.6 In Vitro Diagnostics Solution Providers: Distribution by Annual Revenue (FY23, USD Billion)
Table 23.7 Abbott: Financial Information (USD Billion)
Table 23.8 Agilent: Financial Information (USD Billion)
Table 23.9 BD: Financial Information (USD Billion)
Table 23.10 bioMérieux: Financial Information (EUR Billion)
Table 23.11 Bio-Rad: Financial Information (USD Billion)
Table 23.12 Danaher: Financial Information (USD Billion)
Table 23.13 Qiagen: Financial Information (USD Billion)
Table 23.14 Quest Diagnostics: Financial Information (USD Billion)
Table 23.15 QuidelOrtho: Financial Information (USD Billion)
Table 23.16 Roche: Financial Information (CHF Billion)
Table 23.17 Siemens Healthineers: Financial Information (EUR Billion)
Table 23.18 Sysmex: Financial Information (EUR Billion)
Table 23.19 DiaSorin: Financial Information (USD Billion)
Table 23.20 Exact Sciences: Financial Information (USD Billion)
Table 23.21 Fujifilm: Financial Information (USD Billion)
Table 23.22 Gold Standard Diagnostics: Financial Information (EUR Billion)
Table 23.23 Grifols: Financial Information (USD Billion)
Table 23.24 Hologic: Financial Information (USD Billion)
Table 23.25 Illumina: Financial Information (USD Billion)
Table 23.26 LabCorp: Financial Information (USD Billion)
Table 23.27 Thermo Fisher Scientific: Financial Information (USD Billion)
Table 23.28 Werfen: Financial Information (CHF Billion)
Table 23.29 Global In Vitro Diagnostics Market, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.30 Global In Vitro Diagnostics Market, Forecasted Estimates (till 2035): Conservative Scenario (USD Billion)
Table 23.31 Global In Vitro Diagnostics Market, Forecasted Estimates (till 2035): Optimistic Scenario (USD Billion)
Table 23.32 In Vitro Diagnostics Market: Distribution by Test Type, 2018, 2024 And 2035
Table 23.33 In Vitro Diagnostics Market for Laboratory Testing, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.34 In Vitro Diagnostics Market for Point-of-Care Testing, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.35 In Vitro Diagnostics Market: Distribution by Type of Offering, 2018, 2024 And 2035
Table 23.36 In Vitro Diagnostics Market for Reagents, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.37 In Vitro Diagnostics Market for Instruments, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.38 In Vitro Diagnostics Market for In-house Instruments, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.39 In Vitro Diagnostics Market for Outsourced Instruments, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.40 In Vitro Diagnostics Market for Services, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.41 In Vitro Diagnostics Market: Distribution by Type of Technology, 2018, 2024 And 2035
Table 23.42 In Vitro Diagnostics Market for Immunoassay, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.43 In Vitro Diagnostics Market for Chemiluminescence Immunoassays, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.44 In Vitro Diagnostics Market for ELISA, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.45 In Vitro Diagnostics Market for ELISPOT, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.46 In Vitro Diagnostics Market for Immunofluorescence Assays, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.47 In Vitro Diagnostics Market for Rapid Tests, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.48 In Vitro Diagnostics Market for Other Immunoassays, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.49 In Vitro Diagnostics Market for Clinical Chemistry, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.50 In Vitro Diagnostics Market for Electrolyte Panels, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.51 In Vitro Diagnostics Market for Lipid Profiles, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.52 In Vitro Diagnostics Market for Liver Panels, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.53 In Vitro Diagnostics Market for Metabolic Panels, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.54 In Vitro Diagnostics Market for Renal Profiles, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.55 In Vitro Diagnostics Market for Other Clinical Chemistry Tests, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.56 In Vitro Diagnostics Market for Molecular Diagnostics, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.57 In Vitro Diagnostics Market for PCR, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.58 In Vitro Diagnostics Market for In situ Hybridization, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.59 In Vitro Diagnostics Market for Isothermal Nucleic Acid Amplification Technology, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.60 In Vitro Diagnostics Market for Next Generation Sequencing, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.61 In Vitro Diagnostics Market for Microarrays, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.62 In Vitro Diagnostics Market for Mass Spectrometry, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.63 In Vitro Diagnostics Market for Other Molecular Diagnostic Tests, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.64 In Vitro Diagnostics Market for Hematology, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.65 In Vitro Diagnostics Market for Other Technologies, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.66 In Vitro Diagnostics Market: Distribution by Therapeutic Area, 2018, 2024 And 2035
Table 23.67 In Vitro Diagnostics Market for Infectious Diseases, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.68 In Vitro Diagnostics Market for COVID-19, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.69 In Vitro Diagnostics Market for Healthcare-associated Infections, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.70 In Vitro Diagnostics Market for Hepatitis, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.71 In Vitro Diagnostics Market for HIV, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.72 In Vitro Diagnostics Market for Respiratory Infections (Excluding COVID-19), Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.73 In Vitro Diagnostics Market for STD, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.74 In Vitro Diagnostics Market for Other Infectious Diseases, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.75 In Vitro Diagnostics Market for Cardiovascular Diseases, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.76 In Vitro Diagnostics Market for Oncological Disorders, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.77 In Vitro Diagnostics Market for Diabetes, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.78 In Vitro Diagnostics Market for Autoimmune Diseases, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.79 In Vitro Diagnostics Market for Renal Disorders, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.80 In Vitro Diagnostics Market for Other Therapeutic Areas, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.81 In Vitro Diagnostics Market: Distribution by End Users, 2018, 2024 And 2035
Table 23.82 In Vitro Diagnostics Market for Hospitals, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.83 In Vitro Diagnostics Market for Laboratories, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.84 In Vitro Diagnostics Market for Large Laboratories, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.85 In Vitro Diagnostics Market for Small and Medium-sized Laboratories, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.86 In Vitro Diagnostics Market for Other End Users, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.87 In Vitro Diagnostics Market: Distribution by Geography, 2018, 2024 And 2035
Table 23.88 In Vitro Diagnostics Market in North America, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.89 In Vitro Diagnostics Market in the US, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.90 In Vitro Diagnostics Market in Canada, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.91 In Vitro Diagnostics Market in Europe, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.92 In Vitro Diagnostics Market in Austria, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.93 In Vitro Diagnostics Market in Belgium, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.94 In Vitro Diagnostics Market in France, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.95 In Vitro Diagnostics Market in Germany, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.96 In Vitro Diagnostics Market in Italy, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.97 In Vitro Diagnostics Market in the Netherlands, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.98 In Vitro Diagnostics Market in Poland, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.99 In Vitro Diagnostics Market in Spain, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.100 In Vitro Diagnostics Market in Switzerland, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.101 In Vitro Diagnostics Market in the UK, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.102 In Vitro Diagnostics Market in Rest of the Europe, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.103 In Vitro Diagnostics Market in Asia, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.104 In Vitro Diagnostics Market in China, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.105 In Vitro Diagnostics Market in India, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.106 In Vitro Diagnostics Market in Indonesia, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.107 In Vitro Diagnostics Market in Japan, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.108 In Vitro Diagnostics Market in Singapore, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.109 In Vitro Diagnostics Market in South Korea, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.110 In Vitro Diagnostics Market in Thailand, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.111 In Vitro Diagnostics Market in Rest of the Asia, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.112 In Vitro Diagnostics Market in Latin America, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.113 In Vitro Diagnostics Market in Brazil, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.114 In Vitro Diagnostics Market in Argentina, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.115 In Vitro Diagnostics Market in Mexico, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.116 In Vitro Diagnostics Market in Rest of Latin America, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.117 In Vitro Diagnostics Market in Middle East and North Africa, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.118 In Vitro Diagnostics Market in Egypt, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.119 In Vitro Diagnostics Market in Israel, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.120 In Vitro Diagnostics Market in Saudi Arabia, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.121 In Vitro Diagnostics Market in Rest of Middle East and North Africa, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.122 In Vitro Diagnostics Market in Rest of the World, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.123 In Vitro Diagnostics Market in Australia, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.124 In Vitro Diagnostics Market in New Zealand, Historical Trends (2018-2023) and Forecasted Estimates (till 2035) (USD Billion)
Table 23.125 In Vitro Diagnostics Market: Distribution of Leading Players by Annual Revenues (FY23, USD Billion)

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Agilent
  • Becton Dickinson
  • bioMérieux
  • Bio-Rad
  • Danaher Corporation
  • DiaSorin
  • Exact Sciences
  • Fujifilm
  • Gold Standard Diagnostics
  • Grifols
  • Hologic
  • Illumina
  • LabCorp
  • Qiagen
  • Quest Diagnostics
  • QuidelOrtho
  • Roche
  • Siemens Healthineers
  • Sysmex
  • Thermo Fisher Scientific
  • Werfen

Methodology

 

 

Loading
LOADING...

Related Topics

Related Reports

U.S. In-Vitro Diagnostics Market - Focused Insights 2024-2029 - Product Image

U.S. In-Vitro Diagnostics Market - Focused Insights 2024-2029

  • Report
  • 115 Pages
  • United States
From
North America In-Vitro Diagnostics Market Forecast to 2030 - Regional Analysis - by Product & Services, Technology, Application, and End User - Product Image

North America In-Vitro Diagnostics Market Forecast to 2030 - Regional Analysis - by Product & Services, Technology, Application, and End User

  • Report
  • 112 Pages
  • North America
From
Infectious Disease In Vitro Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents, Software), Technology, Application, Test Location, Region, and Segment Forecasts, 2024-2030 - Product Image

Infectious Disease In Vitro Diagnostics Market Size, Share & Trends Analysis Report by Product (Instruments, Reagents, Software), Technology, Application, Test Location, Region, and Segment Forecasts, 2024-2030

  • Report
  • 190 Pages
  • Global
From
In Vitro Diagnostics Quality Control Market Size, Share & Trends Analysis Report by Product (Controls, Calibrators), Type (Quality Control, Quality Assurance Services), Application, Manufacturer Type, End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

In Vitro Diagnostics Quality Control Market Size, Share & Trends Analysis Report by Product (Controls, Calibrators), Type (Quality Control, Quality Assurance Services), Application, Manufacturer Type, End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 185 Pages
  • Global
From
In-Vitro Diagnostics Instrument Market by Product, End User - Global Forecast 2025-2030 - Product Image

In-Vitro Diagnostics Instrument Market by Product, End User - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From

About the In Vitro Diagnostics Market

In Vitro Diagnostics (IVD) is a medical technology used to diagnose diseases and conditions through the analysis of bodily fluids and tissues. It is used to detect, diagnose, and monitor diseases, as well as to assess the effectiveness of treatments. IVD tests are performed in laboratories, hospitals, and other healthcare settings. IVD tests are used to detect a wide range of conditions, including infections, genetic disorders, and cancer. They can also be used to monitor the progress of a disease or to assess the effectiveness of a treatment. IVD tests are used to detect and measure the presence of specific molecules, such as proteins, hormones, and enzymes, in a sample. IVD tests are performed using a variety of technologies, including immunoassays, molecular diagnostics, and flow cytometry. These tests are used to diagnose a wide range of conditions, including infectious diseases, genetic disorders, and cancer. Some of the major companies in the IVD market include Abbott Laboratories, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.